Aspin Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based pharmaceutical manufacturer with branded portfolios across gastroenterology, cardiology, neuropsychiatry, endocrinology and women’s health.
Aspin Pharma products in Pakistan
Aspin Pharma has 105 medicine presentations registered in Pakistan under 47 brands, covering 44 generic medicines. Most of its products are in Anti-infectives, Hematology & thrombosis and Endocrine & metabolic. Its brands with the most registered strengths and packs are Baroxa (Rivaroxaban), Emaxy (Empagliflozin), Exermet (Metformin) and Ondaset (Ondansetron). 105 products have an official DRAP price on MedInfoBase. See all 47 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Aspin Pharma (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 10 & 25, Sector 20, Korangi Industrial Area, Karachi 74900, Pakistan · 74900
- Website
- aspin.com.pk ↗
- Phone
- +92 21 111 515 515; +92 21 35045560-62
- info@aspin.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Aspin Pharma is priced against the market
94 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amlohyp | Amlodipine | 2.5 mg | Tablet | 2 x10's | 098592 | PKR 91.56 | PKR 4.58/tablet | 🔒 Pharma Pro |
| Amlohyp | Amlodipine | 5 mg | Tablet | 2 x10's | 098593 | PKR 168.60 | PKR 8.43/tablet | 🔒 Pharma Pro |
| Amlohyp | Amlodipine | 10 mg | Tablet | 2 x10's | 098594 | PKR 245.37 | PKR 12.27/tablet | 🔒 Pharma Pro |
| Artrine | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 14's | 100110 | PKR 578.29 | PKR 41.31/tablet | 🔒 Pharma Pro |
| Artrine | Artemether | 40 mg | Tablet | 8's | 100111 | PKR 528.91 | PKR 66.11/tablet | 🔒 Pharma Pro |
| Artrine | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 6's | 100112 | PKR 667.52 | PKR 111.25/tablet | 🔒 Pharma Pro |
| Aspimide Tablet 100mgRegistry verified | Acotiamide HCl hydrate | — | — | — | 130687Official source ↗ | No indexed price | — | — |
| Aspimox | Moxifloxacin | 400 mg | Tablet | 5's | 097205 | PKR 762.72 | PKR 152.54/tablet | 🔒 Pharma Pro |
| Aspinem | Meropenem | 500 mg | Injection | 1's | 116176 | PKR 1,239.18 | PKR 1,239.18/vial/unit | 🔒 Pharma Pro |
| Aspinem | Meropenem | 1 g | Injection | 1's | 116177 | PKR 2,316.23 | PKR 2,316.23/vial/unit | 🔒 Pharma Pro |
| Aspracin | Azithromycin | 250 mg | Tablet | 1 x6's | 098797 | PKR 247.84 | PKR 41.31/tablet | 🔒 Pharma Pro |
| Aspracin | Azithromycin | 500 mg | Tablet | 1 x6's | 098798 | PKR 445.87 | PKR 74.31/tablet | 🔒 Pharma Pro |
| Aspracin | Azithromycin | 200 mg/5 mL | Oral suspension | 15ml | 127978 | PKR 205.38 | PKR 13.69/mL | 🔒 Pharma Pro |
| Axavon Tablet 10 mgRegistry verified | Vonoprazan fumarate Eq. to Vonoprazan | — | — | — | 125467Official source ↗ | No indexed price | — | — |
| Axavon Tablet 20 mgRegistry verified | Vonoprazan fumarate Eq. to Vonoprazan | — | — | — | 125468Official source ↗ | No indexed price | — | — |
| Axovir | Aciclovir | 5% | Cream | 10gm | 089006 | PKR 336.96 | PKR 33.70/g | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 10 mg | Tablet | 14's | 089303 | PKR 7,892.47 | PKR 563.75/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 10 mg | Tablet | 1 x10's | 089303 | PKR 5,521.90 | PKR 552.19/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 15 mg | Tablet | 7's | 089304 | PKR 5,196.51 | PKR 742.36/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 15 mg | Tablet | 10's | 089304 | PKR 7,050.61 | PKR 705.06/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 15 mg | Tablet | 14's | 089304 | PKR 9,871.52 | PKR 705.11/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 20 mg | Tablet | 7's | 089305 | PKR 6,576.18 | PKR 939.45/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 20 mg | Tablet | 10's | 089305 | PKR 8,925.60 | PKR 892.56/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 20 mg | Tablet | 14's | 089305 | PKR 12,496.18 | PKR 892.58/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 2.5 mg | Tablet | 7's | 100113 | PKR 1,419.27 | PKR 202.75/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 2.5 mg | Tablet | 10's | 100113 | PKR 2,028.54 | PKR 202.85/tablet | 🔒 Pharma Pro |
| Baroxa | Rivaroxaban | 2.5 mg | Tablet | 14's | 100113 | PKR 2,839.86 | PKR 202.85/tablet | 🔒 Pharma Pro |
| Celedopa | Methyldopa | 250 mg | Tablet | 100's | 114304 | PKR 1,614.41 | PKR 16.14/tablet | 🔒 Pharma Pro |
| Clobecort Ointment 0.05%Registry verified | Clobetasol propionate | — | — | — | 089217Official source ↗ | No indexed price | — | — |
| Daktacort | Hydrocortisone | 2 % | Cream | 10gm | 009084 | PKR 185.68 | PKR 18.57/g | No comparator |
| Daktarin | Miconazole | 2 % | Cream | 10gm | 005480 | PKR 176.46 | PKR 17.65/g | 🔒 Pharma Pro |
| Daktarin Oral | Miconazole | 20 mg/g | Gel | 20gm | 009078 | PKR 256.48 | PKR 12.82/g | 🔒 Pharma Pro |
| Dasavir | Daclatasvir | 30 mg | Tablet | 28's | 088251 | PKR 5,549.14 | PKR 198.18/tablet | 🔒 Pharma Pro |
| Dasavir | Daclatasvir | 60 mg | Tablet | 28's | 088252 | PKR 9,376.32 | PKR 334.87/tablet | 🔒 Pharma Pro |
| Dasavir | Daclatasvir | 90 mg | Tablet | 28's | 094796 | PKR 13,533.95 | PKR 483.36/tablet | No comparator |
| Dydrogest 10mg TabletRegistry verified | Dydrogesterone | — | — | — | 096247Official source ↗ | No indexed price | — | — |
| Ellgora Tablet 150mgRegistry verified | Elagolix Sodium Eq. to Elagolix | — | — | — | 137346Official source ↗ | No indexed price | — | — |
| Ellgora Tablet 200mgRegistry verified | Elagolix Sodium Eq. to Elagolix | — | — | — | 137345Official source ↗ | No indexed price | — | — |
| Emaxy | Empagliflozin | 10 mg | Tablet | 30's | 120368 | PKR 2,781.46 | PKR 92.72/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 10 mg | Tablet | 10's | 120368 | PKR 945.49 | PKR 94.55/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 10 mg | Tablet | 14's | 120368 | PKR 1,324.50 | PKR 94.61/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 10 mg | Tablet | 28's | 120368 | PKR 2,596.03 | PKR 92.72/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 25 mg | Tablet | 30's | 120369 | PKR 3,329.60 | PKR 110.99/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 25 mg | Tablet | 10's | 120369 | PKR 1,132.96 | PKR 113.30/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 25 mg | Tablet | 14's | 120369 | PKR 1,585.33 | PKR 113.24/tablet | 🔒 Pharma Pro |
| Emaxy | Empagliflozin | 25 mg | Tablet | 28's | 120369 | PKR 3,107.49 | PKR 110.98/tablet | 🔒 Pharma Pro |
| Exermet | Metformin | 500 mg | Tablet | 5 x10's | 098912 | PKR 136.47 | PKR 2.73/tablet | 🔒 Pharma Pro |
| Exermet | Metformin | 850 mg | Tablet | 3 x10's | 098913 | PKR 132.35 | PKR 4.41/tablet | 🔒 Pharma Pro |
| Exermet | Metformin | 250 mg | Tablet | 10 x10's | 098914 | PKR 175.10 | PKR 1.75/tablet | 🔒 Pharma Pro |
| Exermet | Metformin | 500 mg | Extended-release tablet | 5 x10's | 098915 | PKR 140.29 | PKR 2.81/tablet | 🔒 Pharma Pro |
All 47 Aspin Pharma brands in Pakistan
- Amlohyp Amlodipine · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Artrine Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 40 mg tablet, 80 mg + 480 mg tablet
- Aspimox Moxifloxacin · 400 mg tablet
- Aspinem Meropenem · 1 g injection, 500 mg injection
- Aspracin Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Axovir Aciclovir · 5% cream
- Baroxa Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
- Celedopa Methyldopa · 250 mg tablet
- Daktacort Hydrocortisone · 2 % cream
- Daktarin Miconazole · 2 % cream
- Daktarin Oral Miconazole · 20 mg/g gel
- Dasavir Daclatasvir · 30 mg tablet, 60 mg tablet, 90 mg tablet
- Emaxy Empagliflozin · 10 mg tablet, 25 mg tablet
- Exermet Metformin · 1000 mg tablet, 250 mg tablet, 500 mg tablet
- Fitzloc Levetiracetam · 250 mg tablet, 500 mg tablet
- Flucoaid Fluconazole · 150 mg capsule, 50 mg capsule
- Gyno-Daktarin Miconazole · 2 % cream
- Imodium Loperamide HCl · 2 mg capsule
- Impecin Mupirocin · 2% w/w ointment
- Iroxide Elemental Iron, Iron polymaltose complex · 100 mg tablet, 50 mg/mL + 50 mg drops
- M-Span Cefixime · 400 mg capsule
- M-Span Dry Cefixime · 200 mg/5 mL suspension
- M-Span Dry Suspension100mg/5ml Cefixime · 100 mg/5 mL suspension
- Maldip Dihydroartemisinin + Piperaquine · 40 mg + 320 mg tablet
- Mi-Tazo Piperacillin + tazobactam · 2 g + 0.25 g injection, 4.0 g + 0.5 g injection
- Misort Misoprostol · 100 mcg tablet, 200 mcg tablet
- Morning Pill Levonorgestrel · 0.75 mg tablet
- Obsarib Ribavirin · 500 mg tablet, 600 mg tablet
- Obsarox Deferasirox · 125 mg tablet, 250 mg tablet, 500 mg tablet
- Obzinq Zinc · 20 mg tablet
- Obzitic Linezolid · 600 mg tablet
- Ondaset Ondansetron · 4 mg tablet, 4 mg/5 mL solution, 8 mg tablet
- Onem Imipenem + Cilastatin · 500 mg + 500 mg injection
- Ovafin Clomifene citrate · 50 mg tablet
- Plan Pill Levonorgestrel · 0.15 mg tablet
- Ronidazole Metronidazole · 200 mg tablet, 400 mg tablet
- Roxyquin Hydroxychloroquine · 200 mg tablet
- Sepidyl Chlorhexidine, Chlorhexidine gluconate · 4% w/w gel, 7.1% w/w (eq. chlorhexidine 4% w/w) gel, 7.1% w/w (equiv. chlorhexidine 4% w/w) gel
- Sofhep Sofosbuvir · 400 mg tablet
- Sofvel 400mg Sofosbuvir · 400 mg tablet
- Sporanox Itraconazole · 100 mg capsule
- Taklida Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
- Tenaspin Tenofovir disoproxil · 300 mg tablet
- Trimzol Clotrimazole · 10 mg cream
- Trimzol-H Clotrimazole + Hydrocortisone · 10 mg + 10 mg cream
- Vermox Mebendazole · 100 mg tablet, 500 mg tablet
- Virunix-B Entecavir · 0.5 mg tablet, 1 mg tablet
Aspin Pharma: common questions
How many products does Aspin Pharma have in Pakistan?
Aspin Pharma has 105 registered medicine presentations in Pakistan, sold under 47 brands and covering 44 generic medicines.
What are the main brands of Aspin Pharma?
By number of registered strengths and packs, its largest brands are Baroxa (Rivaroxaban), Emaxy (Empagliflozin), Exermet (Metformin), Ondaset (Ondansetron) and Sepidyl (Chlorhexidine, Chlorhexidine gluconate). This is not a sales ranking.
Which therapy areas does Aspin Pharma cover?
The most products are in Anti-infectives (48), Hematology & thrombosis (15), Endocrine & metabolic (13), Reproductive & genitourinary (7) and Gastrointestinal & hepatology (6).
Where can I see Aspin Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.